The Health Marketing Daily | Peptidi, via libera della FDA tra | Drinking orange juice every day may | 'A tax on being thin': only

The Health Marketing Daily — August 18, 2026 In this episode: • The FDA's approval of peptides for commercial sale — amid conflict-of-interest allegations and unresolved safety concerns — has direct implications for European brands watching how this ingredient category is being regulated on both sides of the Atlantic. • New research showing that daily orange juice consumption influences thousands of genes linked to inflammation and immunity gives functional food and nutraceutical brands compelling new science to build campaigns around flavonoid and polyphenol ingredients. • New UK analysis showing that GLP-1 drugs only deliver net food savings for households earning close to £100,000 signals a major affordability barrier — and a significant market opportunity for lower-cost functional nutrition alternatives positioned at the mass market. • Wildfire seasons are now reliably creating a new consumer health anxiety — and a startup called Climatic is among the first brands to build an entire product and marketing strategy around everyday lung health, signalling the emergence of a credible new supplement and wellness category. Hosted by Marco & Klara. New episode every weekday. Tags: health marketing, nutraceuticals, supplements, functional nutrition, wellness, clinical evidence, regulatory, consumer health

What is The Health Marketing Daily?

The daily briefing for professionals in health, nutrition, and wellness marketing. Every episode covers an ingredient of the day, the latest science and regulatory updates from EFSA and beyond, and the brand and market moves shaping the nutraceutical industry. Hosted by Klara and Marco — evidence-based, no hype, no bro-science. Built for formulators, brand managers, regulatory affairs teams, and anyone building in the health and nutrition space.